Zonisamide Versus Propranolol in Migraine - Trial NCT06361446
Access comprehensive clinical trial information for NCT06361446 through Pure Global AI's free database. This Phase 3 trial is sponsored by Kafrelsheikh University and is currently Recruiting. The study focuses on Migraine. Target enrollment is 600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kafrelsheikh University
Timeline & Enrollment
Phase 3
Mar 29, 2024
Apr 20, 2025
Primary Outcome
The change in migraine days per 28 days
Summary
Investigators aim to compare the effect of zonisamide versus propranolol in migraine by
 assessing the absolute reduction in MMD in each group, the percentage of patients who
 achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline
 frequency
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06361446
Non-Device Trial